Ciclesonide for the treatment of airway disease in horses
US-2017079988-A1 · Mar 23, 2017 · US
US10925964B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10925964-B2 |
| Application number | US-201314132578-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 18, 2013 |
| Priority date | Dec 21, 2012 |
| Publication date | Feb 23, 2021 |
| Grant date | Feb 23, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.
Opening claim text (preview).
The invention claimed is: 1. A pharmaceutical formulation consisting of ciclesonide, hydrochloric acid, water and ethanol, wherein said formulation has a −log 10 [H+] of 4.5, and said formulation includes the following amounts of: concentration Ingredient [in 100 mL] Ciclesonide 3.0 g HCl (0.1 M) 0.0424 mL Ethanol (100% v/v 68.8 g ethanol/water) Water 11.5 g. 2. An inhalation kit comprising a pharmaceutical formulation according to claim 1 , an inhaler device and an instruction leaflet comprising instructions and directions for use. 3. The inhalation kit according to claim 2 , wherein said inhaler device nebulizes said pharmaceutical formulation. 4. The inhalation kit according to claim 2 , where said inhaler device is a pressurized metered dose inhaler. 5. The inhalation kit according to claim 2 , wherein said inhaler device is a non-pressurized metered dose aqueous/ethanolic droplet inhaler. 6. The inhalation kit according to claim 2 , wherein said inhaler device comprises an adapter for equine use.
containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin (digitoxin {A61K31/7048}) · CPC title
Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; (nasal sprays A61K9/0043; inhalation of vapours of volatile or heated drugs, e.g. essential oils or nicotine, A61K9/007; devices A61M) · CPC title
Drugs for disorders of the respiratory system · CPC title
Solutions {(composition of solutions A61K47/00)} · CPC title
Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.